Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
AUGMENTED ANATOMY from Knokke-Heist, company number BE0707562243, closed financial year 2025 with a result of € -872,850 after tax. For that financial year AUGMENTED ANATOMY recorded a gross margin of € -465,565 and equity of € 104,775. Compared with financial year 2024, the result moved from € -801,746 to € -872,850. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 104,775
▲ € 428,203 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -872,850
▼ 9 % more loss than in 2024
Profit after tax over the fiscal year.
€ 206,330
▲ € 162,739 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3.3 million.
People and assets in 2025
€ 161,294
▼ 24% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 323
▼ 76% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 618,440
▼ 23% vs 2024
€ 93,440 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 43,314
▼ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,224
▼ 33% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -117,358 | € -371,438 | € -337,241 | € -465,565 | ▼ € 128,324 |
| Profit after taxes | € -494,422 | € -785,441 | € -801,746 | € -872,850 | ▼ € 71,104 |
| Equity | € -562,813 | € 325,419 | € -323,428 | € 104,775 | ▲ € 428,203 |
| Total debts | € 1,365,971 | € 678,271 | € 953,180 | € 721,887 | ▼ 24% |
| Cash | € 185,249 | € 337,346 | € 43,591 | € 206,330 | ▲ € 162,739 |
| Retained profit | € -825,313 | € -1,610,755 | € -2,412,501 | € -3,285,351 | ▼ € 872,850 |
| Bank debt | € 1,162,886 | € 494,886 | € 806,902 | € 618,440 | ▼ 23% |
| Balance sheet total | € 803,158 | € 1,003,689 | € 629,753 | € 826,662 | ▲ 31% |
Key figures of AUGMENTED ANATOMY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AUGMENTED ANATOMY?
What happened at AUGMENTED ANATOMY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 872,850. filed late Source: NBB ↗
- MD Consult BV became a director. NBB
- Thierry Haezevoets stepped down as director. NBB
- Mathieu Verbraken became a director. NBB
- Benedicte Laureys became a director. NBB
- Passion4Growth BV became a director. NBB
- Karl Waked became a director. NBB
- Thierry Haezevoets became a director. NBB
In short
From € 494,422 loss in 2022 to € 872,850 loss in 2025.
Paid € 5,880 in corporate taxes since 2022.
A new publication or filing at AUGMENTED ANATOMY? We notify you, reason included.
Follow AUGMENTED ANATOMYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of AMBO HOLDING, MD CONSULT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
AUGMENTED ANATOMYBehind AUGMENTED ANATOMY are Passion4Growth BV, Benoit Hendrickx, Mathieu Verbraken, MD Consult BV, Benedicte Laureys and Karl Waked. The shares are held by AMBO HOLDING (23.4%) and MD CONSULT (20%).
Directors
According to the 2025 annual accounts
Director · represented by Jörgen Schaffers
since 2022
since 2020
Mathieu Verbraken
Director
since 2024
Director · represented by Mario Debel
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, 2PHARMA HOLDING, MD Pharma, Azur Medical, GLOBIFER INTL, CREDOPHAR, 2PHARMA
since 2025
Benedicte Laureys
Director
since 2023
Karl Waked
Director
since 2021
Thierry Haezevoets
Director
since 2021 · until 2025
Shareholders
23.4%
20%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Krokussenpad 2A
8301 Knokke-Heist
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0707.562.243
- VAT number
- BE 0707.562.243
- Registered office
- Krokussenpad 2A, 8301 Knokke-Heist
- Names & denominations
- AUGMENTED ANATOMY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 October 2018
- Peppol
- Active · Active since 16 Jul 2025
- Activities · NACE
Ontwerpen van computerprogramma’s
Speur- en ontwikkelingswerk op biotechnologisch gebied
Ontwerpen en programmeren van computerprogramma's